Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A test for sensitivity of normal tissue to radiation damage?

23.09.2003


Researchers find genetic variations that could be used to help tailor radiotherapy doses to individual patients



Researchers in Denmark have identified specific changes in the basic building blocks of DNA that can affect how sensitive a patient is to radiotherapy. Their findings offer a glimmer of hope that it might be possible to develop gene-based predictive tests that would enable doctors to work out the highest dose a patient could tolerate, thereby improving the efficacy of radiotherapy treatment.

Dr Nicolaj Andreassen told a news conference at ECCO12 – The European Cancer Conference that he and his colleagues had studied five genes that were known to be involved in the body’s response to radiation. They had looked at the sequence of the four different nucleotides (A, T, G and C) that make up the DNA of each gene and found particular places in the genetic sequence where the sequence varied from the norm in a way that could affect the proteins that the gene was responsible for coding for (or making).


The spots on the genes where these variations are found are called single nucleotide polymorphisms (SNPs), and they represent sites where a number of people have a nucleotide that is different to the nucleotide that most people would have – for instance, a T instead of a C. SNPs mean that certain people may have a protein that works in a different way to the corresponding protein in other people, and these differences in protein function contribute to making us different to one another and with bodies that behave in different ways to external challenges such as radiotherapy.

Dr Andreassen, a research fellow at the Department of Experimental Clinical Oncology at Aarhus University Hospital, Denmark, found that in 41 women treated with radiotherapy after a mastectomy between 1978 and 1982, five SNPs in four genes correlated with different levels of two types of radiation damage: subcutaneous fibrosis (scarring under the skin) and telangiectasia (an increase in small blood vessels under the skin).

The XRCC1 and XRCC3 genes code for proteins involved in the repair of radiation-induced DNA damage; SOD2 is the gene for the protein that eliminates toxic reactive oxygen species, which are known to be generated in large quantities when tissues are irradiated; TGFB1 produces a protein that is assumed to play a major role in the development of tissue fibrosis. Dr Andreassen found that SNPs on the XRCC1, XRCC3, SOD2 and TGFB1 were all associated with the risk of radiation-induced subcutaneous fibrosis. The XRCC3 gene was also associated with the risk of telangiectasia.

Everyone has two copies of a gene, one inherited from the father and one from the mother. Dr Andreassen and colleagues placed their patients into three groups: two groups were for patients who had genes where both copies either had a certain variant of the SNP or did not (homozygous), and a third group for patients where one copy of the gene had the variant SNP and the other did not (heterozygous).

He said: "We observed that patients with two copies of one nucleotide (for instance, two Ts) were more radiosensitive than those with two copies of the other nucleotide (for instance, two Cs) whereas those with one of each nucleotide (for instance, a T and a C) at the polymorphic site exhibited intermediate radiosensitivity. This showed that the SNPs influence radiosensitivity, and that a particular genetic pattern at these sites correlates with increased or decreased radiosensitivity.

"For each of the polymorphisms that affected radiosensitivity significantly, we found that patients with two ’favourable copies’ tolerated a 15-25% higher radiation dose compared to those with two ’unfavourable copies’. Typically, those with one favourable and one unfavourable copy, at the polymorphic site, tolerated an approximately 10% higher radiation dose than those with two unfavourable copies, hence their radiosensitivity was intermediate.

"Our findings indicate that normal tissue radiosensitivity should be considered as a trait dependent on the combined effect of variations in several genes, and that SNPs could constitute a substantial proportion of such genetic determinants. This means that normal tissue radiosensitivity could be predicted from individual genetic patterns or profiles."

Dr Andreassen said that although the results needed to be confirmed and more work was necessary, this could be the first step to developing tests that could predict the way individual patients would respond to radiotherapy and improving treatments.

At present, radiotherapy doses are often restricted by what the most radiosensitive patients can tolerate, keeping the risk of severe persistent normal tissue damage below 5-10%, despite the fact that many patients could tolerate a larger dose without severe tissue reactions.

"The aim of developing predictive assays is to enable individual tailoring of treatments. If normal tissue radiosensitivity could be reliably predicted prior to treatment, the radioresistant patients could be offered a somewhat higher dose. In many cases this would increase the chances of cure substantially. Occasionally, more than one treatment strategy exists for the same disease. In such situations predictive assays could be used to decide whether radiotherapy should be included in the treatment," explained Dr Andreassen.

"Even though our results should be regarded as preliminary, we consider them very interesting and important. They shed new light on the genetic basis that seems to underlie differences in normal tissue radiosensitivity and provide backing for the concept of gene-based predictive tests for patients."

The research will be fed into the ESTRO project GENEPI, which aims to collect biological specimens and clinical data from European radiotherapy patients with the intention of establishing correlations between genetic markers and clinical outcome. The project should give researchers important information about the influence of genetic factors on normal tissue radiosensitivity so that findings from this and other research can be put to good use in the clinic to improve treatments for patients.


Note: The study was supported by grants from the Danish Cancer Society, the Clinical Research Unit at the Department of Oncology, Aarhus University Hospital, the Danish Medical Research Council and ’Max og Inger Wørzners Mindelegat’.

Further information:
ECCO 12 press office: Sunday 21 September – Thursday 25 September
Tel: 45-3252-4163 or 45-3252-4179
Fax: 45 32524171

Margaret Willson: mobile: 44-7973 853347 Email: m.willson@mwcommunications.org.uk
Mary Rice: mobile: 44-7803-048897 Email: mary.rice@blueprintpartners.be
Emma Mason: mobile: 44-7711-296986 Email: wordmason@aol.com

Margaret Willson | EurekAlert!
Further information:
http://www.fecs.be/

More articles from Health and Medicine:

nachricht Custom-tailored strategy against glioblastomas
26.09.2016 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht New leukemia treatment offers hope
23.09.2016 | King Abdullah University of Science and Technology

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New welding process joins dissimilar sheets better

Friction stir welding is a still-young and thus often unfamiliar pressure welding process for joining flat components and semi-finished components made of light metals.
Scientists at the University of Stuttgart have now developed two new process variants that will considerably expand the areas of application for friction stir welding.
Technologie-Lizenz-Büro (TLB) GmbH supports the University of Stuttgart in patenting and marketing its innovations.

Friction stir welding is a still-young and thus often unfamiliar pressure welding process for joining flat components and semi-finished components made of...

Im Focus: First quantum photonic circuit with electrically driven light source

Optical quantum computers can revolutionize computer technology. A team of researchers led by scientists from Münster University and KIT now succeeded in putting a quantum optical experimental set-up onto a chip. In doing so, they have met one of the requirements for making it possible to use photonic circuits for optical quantum computers.

Optical quantum computers are what people are pinning their hopes on for tomorrow’s computer technology – whether for tap-proof data encryption, ultrafast...

Im Focus: OLED microdisplays in data glasses for improved human-machine interaction

The Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP has been developing various applications for OLED microdisplays based on organic semiconductors. By integrating the capabilities of an image sensor directly into the microdisplay, eye movements can be recorded by the smart glasses and utilized for guidance and control functions, as one example. The new design will be debuted at Augmented World Expo Europe (AWE) in Berlin at Booth B25, October 18th – 19th.

“Augmented-reality” and “wearables” have become terms we encounter almost daily. Both can make daily life a little simpler and provide valuable assistance for...

Im Focus: Artificial Intelligence Helps in the Discovery of New Materials

With the help of artificial intelligence, chemists from the University of Basel in Switzerland have computed the characteristics of about two million crystals made up of four chemical elements. The researchers were able to identify 90 previously unknown thermodynamically stable crystals that can be regarded as new materials. They report on their findings in the scientific journal Physical Review Letters.

Elpasolite is a glassy, transparent, shiny and soft mineral with a cubic crystal structure. First discovered in El Paso County (Colorado, USA), it can also be...

Im Focus: Complex hardmetal tools out of the 3D printer

For the first time, Fraunhofer IKTS shows additively manufactured hardmetal tools at WorldPM 2016 in Hamburg. Mechanical, chemical as well as a high heat resistance and extreme hardness are required from tools that are used in mechanical and automotive engineering or in plastics and building materials industry. Researchers at the Fraunhofer Institute for Ceramic Technologies and Systems IKTS in Dresden managed the production of complex hardmetal tools via 3D printing in a quality that are in no way inferior to conventionally produced high-performance tools.

Fraunhofer IKTS counts decades of proven expertise in the development of hardmetals. To date, reliable cutting, drilling, pressing and stamping tools made of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

HLF: From an experiment to an establishment

29.09.2016 | Event News

European Health Forum Gastein 2016 kicks off today

28.09.2016 | Event News

Laser use for neurosurgery and biofabrication - LaserForum 2016 focuses on medical technology

27.09.2016 | Event News

 
Latest News

New Multiferroic Materials from Building Blocks

29.09.2016 | Materials Sciences

Silicon Fluorescent Material Developed Enabling Observations under a Bright “Biological Optical Window”

29.09.2016 | Materials Sciences

X-shape Bio-inspired Structures

29.09.2016 | Interdisciplinary Research

VideoLinks
B2B-VideoLinks
More VideoLinks >>>